Aerie Pharmaceuticals Competitors and Similar CompaniesClear all
Aerie Pharmaceuticals's competitors and similar companies include scPharmaceuticals.
 Aerie Pharmaceuticals Aerie Pharmaceuticals is a clinical-stage pharmaceutical company focused on the discovery, development and commercialization of first-in-class therapies for the treatment of patients with glaucoma and other diseases of the eye. |  scPharmaceuticals scPharmaceuticals, a biopharmaceutical company, develops a portfolio of transformative pharmaceutical products for subcutaneous delivery. | |
Founding Date | Founding Date 2005 | Founding Date 2014 |
Type | Type Public | Type Public |
Tags | ||
Locations | Locations Irvine, US HQ Dublin, IE 千代田区, JP Henley On Thames, GB Bedminster, US Durham, US | Locations Burlington, US HQ |
Employees | Employees 3808% increase | Employees 96256% increase |
Valuation ($) | Valuation ($) 722.2 m | Valuation ($) 221.6 m |
Financial | ||
Revenue (est.) | Revenue (est.) $194.1m (FY, 2021) | Revenue (est.) $36.3m (FY, 2024) |
Cost of goods | Cost of goods $26.8m (FY, 2021) | Cost of goods $11.4m (FY, 2024) |
Net income | Net income ($74.8m) (FY, 2021) | Net income ($85.1m) (FY, 2024) |
Funding | ||
Total funding raised | Total funding raised $ 388.6m | Total funding raised $ 62.5m |
For sources of this data, please see the company profile
View Company Profiles
scPharmaceuticals
HQ
Burlington, US
Employees
96
scPharmaceuticals, a biopharmaceutical company, develops a portfolio of transformative pharmaceutical products for subcutaneous delivery.
View company